FAS and intrahepatic cholangiocarcinoma: The expressions of CCL19, TNFRSF19, TNFRSF4, IL-18, and CXCR4 were higher in ICC patients, while expressions of CXCL2, FAS, and IRF1 were higher in ECC patients.